Skip to main content
. 2018 Jul;33(4):299–308. doi: 10.5001/omj.2018.56

Table 5. Medications used in the management of 22 pediatric patients with Crohn’s disease at the time of diagnosis and during follow-up.

Medications Treated patients, n (%)
Prednisolone 16 (72.7)
Azathioprine 16 (72.7)
Mesalazine 12 (54.5)
Pentasa 7 (31.8)
Asacol 6 (27.3)
Folic acid 9 (40.9)
Iron supplementation 7 (31.8)
Omeprazole 6 (27.3)
Calcium supplementation 6 (27.3)
Multivitamins 6 (27.3)
Biological therapy 5 (22.7)
Adalimumab 4 (18.2)
Infliximab infusion 2 (9.1)